This month, we had the honor of welcoming Lehendakari Imanol Pradales and key members of his government team to our facilities; Mikel Jauregi, Minister of Industry, Energy Transition and Sustainability; Juan Ignacio Pérez Iglesias, Minister of Science, University, and Innovation; and Jaione Ganzarain, Deputy Minister of Technology, Innovation, and Digital Transformation.
During their visit, we had the opportunity to share Viralgen’s mission of bringing advanced treatments to those who need them most, to showcase the science that takes place in our laboratories and give insights on AAVs (Adeno-Associated Virus vectors) manufacturing process, critical to gene therapies.
We are deeply grateful to have hosted these important visitors/ stakeholders and appreciate the continuous support critical for developing innovative therapies in the Basque country. This visit strengthens our commitment to health and innovation, as we work together to advance progress in the field of gene therapies.
News
September 26, 2024
Visit of Lehendakari Imanol Pradales and his team to Viralgen facilities: A step forward in advancing gene therapies
Explore more
Resources
Webinar: Comparing ultracentrifugation versus AEX for successful AAV purification
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format. Historically, full-empty AAV capsid separation performed using an ultracentrifugation density...
READ MORE
November 05, 2024
Resources
Displacement Chromatography for Enrichment of rAAV Genome-Containing Capsids using Weak Organic Acid
Recombinant adeno-associated virus (rAAV) vectors have become essential in gene therapy for delivering therapeutic genes effectively. However, the challenge of separating empty capsids from genome-containing particles remains a significant hurdle,...
READ MORE
October 25, 2024
Resources
Improving Scalability and Productivity of Transient Transfection AAV Production
In the rapidly evolving field of gene therapy, optimizing the production of adeno-associated viral vectors (AAVs) is essential for success. Our latest white paper dives into the advantages of using transient transfection systems for AAV production,...
READ MORE
October 22, 2024